Ampicillin: rise fall and resurgence

Dwarikadhish Kaushik1, Mudit Mohan2, Dhammraj M Borade3

  • 1Consultant Physician, Department of Critical Care Medicine, St Joseph Hospital , Mariyam Nagar, Nandgram Ghaziabad-201003, UP, India .

Insights

Antimicrobial resistance (AMR) is a growing global threat, leading to treatment challenges. Interestingly, Salmonella is regaining susceptibility to ampicillin, offering hope against resistant infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Resistance

Background:

  • Antimicrobial resistance (AMR) poses significant global health challenges, diminishing the efficacy of essential medicines.
  • The rise of resistant pathogens necessitates exploring alternative treatments and drug combinations for infectious diseases.

Purpose of the Study:

  • To investigate the re-emergence of ampicillin susceptibility in Salmonella strains.
  • To understand the implications of changing antimicrobial susceptibility patterns in the context of widespread AMR.

Main Methods:

  • Observational analysis of antimicrobial susceptibility trends in Salmonella.
  • Review of treatment strategies for enteric fever in response to evolving resistance patterns.

Main Results:

  • Salmonella previously resistant to ampicillin shows increasing susceptibility.
  • Resistance to alternative antimicrobials like fluoroquinolones and cephalosporins is also being reported.
  • Potential mechanisms for ampicillin's regained activity include loss of plasmid-mediated resistance or emergence of de novo susceptible strains.

Conclusions:

  • The regaining of ampicillin activity against Salmonella offers a promising development in combating antimicrobial resistance.
  • This phenomenon highlights the dynamic nature of pathogen resistance and the potential for antimicrobial efficacy to be restored.
  • Further research into the mechanisms of resistance loss is crucial, especially given the limited pipeline for new antimicrobial development.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
419
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
381
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
211
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
138
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
331
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.6K